antibody-drug conjugate

BRIEF: WuXi XDC’s revenue, profit jump in 2024

WuXi XDC Cayman Inc. (2268.HK), a provider of contract services for drug companies, said on Wednesday its revenue and profit rose sharply last year on strong demand for services related…
2268.HK

Recent Articles

RECENT ARTICLES

  1. WuXi Biologics
    WuXi Biologics sells vaccine plant as new U.S. law looms
    2269.HK
  2. BRIEF: WuXi AppTec sells advanced therapies units in U.K. and U.S.
    2359.HK 603259.SHG
  3. DPC Dash serves up banner 2024 topped with milestones
    1405.HK
  4. Dida reverses into revenue contraction, falling profits
    2559.HK
  5. Cancer drug maker Genfleet joins Hong Kong IPO influx
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva